These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21037942)

  • 1. Combining an Internal Pilot with an Interim Analysis for Single Degree of Freedom Tests.
    Kairalla JA; Muller KE; Coffey CS
    Commun Stat Theory Methods; 2010 Dec; 39(20):3717-3738. PubMed ID: 21037942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exact test size and power of a Gaussian error linear model for an internal pilot study.
    Coffey CS; Muller KE
    Stat Med; 1999 May; 18(10):1199-214. PubMed ID: 10363340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GLUMIP 2.0:
    Kairalla JA; Coffey CS; Muller KE
    J Stat Softw; 2008 Nov; 28(7):. PubMed ID: 27774042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Operating characteristics of sample size re-estimation with futility stopping based on conditional power.
    Lachin JM
    Stat Med; 2006 Oct; 25(19):3348-65. PubMed ID: 16345019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Futility interim monitoring with control of type I and II error probabilities using the interim Z-value or confidence limit.
    Lachin JM
    Clin Trials; 2009 Dec; 6(6):565-73. PubMed ID: 19933716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing the sample size when the unblinded interim result is promising.
    Chen YH; DeMets DL; Lan KK
    Stat Med; 2004 Apr; 23(7):1023-38. PubMed ID: 15057876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do we need to adjust for interim analyses in a Bayesian adaptive trial design?
    Ryan EG; Brock K; Gates S; Slade D
    BMC Med Res Methodol; 2020 Jun; 20(1):150. PubMed ID: 32522284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic survey of randomised trials that stopped early for reasons of futility.
    Walter SD; Han H; Guyatt GH; Bassler D; Bhatnagar N; Gloy V; Schandelmaier S; Briel M
    BMC Med Res Methodol; 2020 Jan; 20(1):10. PubMed ID: 31948397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stopping boundaries adjusted for sample size reestimation and negative stop.
    Shun Z
    J Biopharm Stat; 2002 Nov; 12(4):485-502. PubMed ID: 12477071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties of internal pilots with the univariate approach to repeated measures.
    Coffey CS; Muller KE
    Stat Med; 2003 Aug; 22(15):2469-85. PubMed ID: 12872303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interim analysis incorporating short- and long-term binary endpoints.
    Niewczas J; Kunz CU; König F
    Biom J; 2019 May; 61(3):665-687. PubMed ID: 30694566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interim futility analysis with intermediate endpoints.
    Goldman B; LeBlanc M; Crowley J
    Clin Trials; 2008; 5(1):14-22. PubMed ID: 18283075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The reassessment of trial perspectives from interim data--a critical view.
    Bauer P; Koenig F
    Stat Med; 2006 Jan; 25(1):23-36. PubMed ID: 16220517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some Distributions and Their Implications for an Internal Pilot Study With a Univariate Linear Model.
    Coffey CS; Muller KE
    Commun Stat Theory Methods; 2000 Jan; 29(12):. PubMed ID: 24307749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical Methods for Bounding Type I Error Rate with an Internal Pilot Design.
    Coffey CS; Kairalla JA; Muller KE
    Commun Stat Theory Methods; 2007; 36(11):. PubMed ID: 24363489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Information-based sample size re-estimation in group sequential design for longitudinal trials.
    Zhou J; Adewale A; Shentu Y; Liu J; Anderson K
    Stat Med; 2014 Sep; 33(22):3801-14. PubMed ID: 24797715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantifying the bias in the estimated treatment effect in randomized trials having interim analyses and a rule for early stopping for futility.
    Walter SD; Han H; Briel M; Guyatt GH
    Stat Med; 2017 Apr; 36(9):1506-1518. PubMed ID: 28183155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing the sample size at interim for a two-sample experiment without Type I error inflation.
    Dunnigan K; King DW
    Pharm Stat; 2010; 9(4):280-7. PubMed ID: 19764040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choosing Interim Sample Sizes in Group Sequential Designs.
    Tarima S; Flournoy N
    Stud Health Technol Inform; 2021 May; 278():11-16. PubMed ID: 34042870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlling test size while gaining the benefits of an internal pilot design.
    Coffey CS; Muller KE
    Biometrics; 2001 Jun; 57(2):625-31. PubMed ID: 11414593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.